ARIAD Pharmaceuticals’ Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment ARIAD Pharmaceuticals, Inc dapoxetine . We are delighted by the quick acceptance of Iclusig in European countries and will now work carefully with the national wellness authorities to create Iclusig available to Philadelphia-positive leukaemia sufferers as fast as possible, mentioned Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD. The clinical development of Iclusig included many leukaemia specialists throughout Europe, and you want to identify their critical functions in bringing Iclusig to patients with resistant or intolerant CML and Ph+ ALL in the EU.
There is no better period for Congress to advance wellness reform. Cover the Uninsured Week is the right time for action. APHA applauds congressional leaders when planning on taking up this critically essential effort and urges Congress to complete the job. .. APHA urges Congress to finalize health reform legislation ‘Cover the Uninsured Week’ May be the Right Time for Action, Says APHA Executive Director Dr. Georges C. Benjamin in Declaration The American Public Wellness Association supports Congress as it seeks to finalize comprehensive wellness reform legislation this week. The measure before Congress and the programs to strengthen it represent the greatest opportunity our country has already established to improve our health and wellness system and strengthen public health.